Intertek Scientific & Regulatory Consultancy, Farnborough, GU14 0 LX, UK.
Intertek Scientific & Regulatory Consultancy, Mississauga, ON L5N 2X7, Canada.
Nutrients. 2018 Mar 15;10(3):357. doi: 10.3390/nu10030357.
The current review examined published data on the intake of all major low-/no-calorie sweeteners-aspartame, acesulfame-K, saccharin, sucralose, cyclamate, thaumatin and steviol glycosides-globally over the last decade. The most detailed and complex exposure assessments were conducted in Europe, following a standardized approach. Japan and Korea similarly had up-to-date and regular intake data available. The data for other Asian countries, Latin America, Australia/New Zealand and global estimates, evaluated by the Joint FAO/WHO Expert Committee on Food Additives (JECFA), while available, were shown to be more limited in terms of design. Overall, the studies conducted since 2008 raised no concerns with respect to exceedance of individual sweetener acceptable daily intake (ADIs) among the general population globally. The data identified do not suggest a shift in exposure over time, with several studies indicating a reduction in intake. However, some data suggest there may have been an increase in the numbers of consumers of low-/no-calorie-sweetened products. Future research should consider a more standardized approach to allow the monitoring of potential changes in exposure based upon events such as sugar reduction recommendations, to ensure there is no shift in intake, particularly for high-risk individuals, including diabetics and children with specific dietary requirements, and to ensure risk management decisions are based on quality intake analyses.
本综述审查了过去十年中全球关于所有主要低热量/无热量甜味剂(阿斯巴甜、乙酰磺胺酸钾、糖精、三氯蔗糖、环己基氨基磺酸钠、甜菊糖甙和甜菊双糖苷)摄入量的已发表数据。在欧洲,采用标准化方法进行了最详细和最复杂的暴露评估。日本和韩国同样提供了最新和定期的摄入量数据。其他亚洲国家、拉丁美洲、澳大利亚/新西兰和全球估计值的数据,由粮农组织/世界卫生组织食品添加剂联合专家委员会(JECFA)进行了评估,虽然可以获得,但在设计方面显得更加有限。总体而言,自 2008 年以来开展的研究并未对全球一般人群中个别甜味剂可接受日摄入量(ADI)的超标提出任何担忧。已确定的数据并未表明随着时间的推移暴露量发生变化,有几项研究表明摄入量有所减少。然而,一些数据表明,使用低热量/无热量甜味剂产品的消费者人数可能有所增加。未来的研究应考虑采用更标准化的方法,以便根据糖摄入量减少等事件监测潜在的暴露变化,以确保摄入量没有变化,特别是对于包括糖尿病患者和有特殊饮食要求的儿童在内的高危人群,并确保风险管理决策基于高质量的摄入量分析。